Clorox CEO Linda Rendle to Step Down for Health Reasons
CLX is trading near its 52-week low of $84.7 (14% above the low).
Summary
Clorox CEO Linda Rendle will step down for health reasons after more than 20 years with the company, including four as CEO. She will remain at the helm during the comprehensive search for her successor. This leadership change follows a period where Clorox completed the acquisition of GOJO Industries, increased its debt, and recently lowered its annual adjusted earnings per share forecast. A CEO transition introduces uncertainty, especially as the company navigates financial pressures and integrates a significant acquisition.
At the time of this announcement, CLX was trading at $96.20 on NYSE in the Trade & Services sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $84.70 to $132.03. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.